Literature DB >> 11122971

Atypical antipsychotic drugs in nonschizophrenic psychiatric disorders.

C A Zarate1, M Vemuri, S Cavanagh, M Land.   

Abstract

This current review looks at the published literature discussing the use of atypical antipsychotics in nonschizophrenic conditions.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11122971     DOI： 10.1007/s11920-000-0070-y

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN： 1523-3812            Impact factor:   5.285


  26 in total

1.  Antidepressant activity and mania associated with risperidone treatment of schizoaffective disorder.

Authors:  M M Dwight; P E Keck; S P Stanton; S M Strakowski; S L McElroy
Journal:  Lancet       Date:  1994-08-20       Impact factor: 79.321

2.  Treatment of refractory rapid cycling bipolar disorder with risperidone.

Authors:  E Vieta; C Gasto; F Colom; A Martinez; A Otero; J Vallejo
Journal:  J Clin Psychopharmacol       Date:  1998-04       Impact factor: 3.153

3.  Results and side effects of treatment with clozapine (leponex R).

Authors:  R Battegay; B Cotar; J Fleischhauer; U Rauchfleisch
Journal:  Compr Psychiatry       Date:  1977 Sep-Oct       Impact factor: 3.735

4.  Risperidone augmentation of serotonin reuptake inhibitors in obsessive-compulsive and related disorders.

Authors:  D J Stein; C Bouwer; S Hawkridge; R A Emsley
Journal:  J Clin Psychiatry       Date:  1997-03       Impact factor: 4.384

5.  Olanzapine response in psychotic depression.

Authors:  A J Rothschild; K S Bates; K L Boehringer; A Syed
Journal:  J Clin Psychiatry       Date:  1999-02       Impact factor: 4.384

6.  Acute treatment of bipolar disorder with adjunctive risperidone in outpatients.

Authors:  S N Ghaemi; G S Sachs; C F Baldassano; C J Truman
Journal:  Can J Psychiatry       Date:  1997-03       Impact factor: 4.356

7.  Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group.

Authors:  M Tohen; T M Sanger; S L McElroy; G D Tollefson; K N Chengappa; D G Daniel; F Petty; F Centorrino; R Wang; S L Grundy; M G Greaney; T G Jacobs; S R David; V Toma
Journal:  Am J Psychiatry       Date:  1999-05       Impact factor: 18.112

8.  Risperidone in the treatment of mania.

Authors:  M Tohen; C A Zarate; F Centorrino; J I Hegarty; M Froeschl; S B Zarate
Journal:  J Clin Psychiatry       Date:  1996-06       Impact factor: 4.384

9.  Lack of efficacy of clozapine monotherapy in refractory obsessive-compulsive disorder.

Authors:  C J McDougle; L C Barr; W K Goodman; G H Pelton; S C Aronson; A Anand; L H Price
Journal:  Am J Psychiatry       Date:  1995-12       Impact factor: 18.112

10.  Clozapine for treatment-refractory mania.

Authors:  J R Calabrese; S E Kimmel; M J Woyshville; D J Rapport; C J Faust; P A Thompson; H Y Meltzer
Journal:  Am J Psychiatry       Date:  1996-06       Impact factor: 18.112
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.